Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | I2 |
| Molecular Weight | 253.8089 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
II
InChI
InChIKey=PNDPGZBMCMUPRI-UHFFFAOYSA-N
InChI=1S/I2/c1-2
Tetraglycine hydroperiodide is an iodine-containing chemical, used for water purification. Tetraglycine hydroperiodide is marketed in tablets; each tablet effectively disinfects 1 liter of clear water or 0.5 liter of tainted water by releasing approximately 8 mg free iodine. It requires approximately 30 minutes to inactivate target microorganisms and make water bacteriologically suitable for drinking. To remove iodine taste, a vitamin C pill is added to the kit.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Necrotizing hepatitis with a fatal outcome after carbimazole therapy]. | 1993 Oct 22 |
|
| Case report: reversible mitral regurgitation and congestive heart failure complicating thyrotoxicosis. | 1996 Mar |
|
| Propylthiouracil-induced rapidly progressive glomerulonephritis associated with antineutrophil cytoplasmic autoantibodies. | 1997 Jul |
|
| Adverse reactions to nonionic iodine in contrast-enhanced computed tomography: usefulness of monitoring vital signs. | 1998 Jul |
|
| Effects of iodine on inducible nitric oxide synthase and cyclooxygenase-2 expression in sulfur mustard-induced skin. | 2001 Feb |
|
| Effects of selenium and iodine on c-fos and c-jun mRNA and their protein expressions in cultured rat hippocampus cells. | 2002 Winter |
|
| Functional expression of sodium iodide symporter (NIS) in human breast cancer tissue. | 2003 Jan |
|
| Thiocyanate induces cell necrosis and fibrosis in selenium- and iodine-deficient rat thyroids: a potential experimental model for myxedematous endemic cretinism in central Africa. | 2004 Feb |
|
| [Effect of high-iodine intake on MBP mRNA expression in cerebrum of filial mice and selenium intervention]. | 2005 Jul |
|
| Inhibition of N-methyl-N-nitrosourea-induced mammary carcinogenesis by molecular iodine (I2) but not by iodide (I-) treatment Evidence that I2 prevents cancer promotion. | 2005 May 31 |
|
| Involvement of tumor necrosis factor-alpha in sulfur mustard-induced skin lesion; effect of topical iodine. | 2005 Nov |
|
| Reverse transcriptase inhibitors down-regulate cell proliferation in vitro and in vivo and restore thyrotropin signaling and iodine uptake in human thyroid anaplastic carcinoma. | 2005 Oct |
|
| Salt dual-fortified with iodine and micronized ground ferric pyrophosphate affects iron status but not hemoglobin in children in Cote d'Ivoire. | 2006 Jul |
|
| Molecular iodine induces caspase-independent apoptosis in human breast carcinoma cells involving the mitochondria-mediated pathway. | 2006 Jul 14 |
|
| The loss of the chloride channel, ClC-5, delays apical iodide efflux and induces a euthyroid goiter in the mouse thyroid gland. | 2006 Mar |
|
| Antiseptics, iodine, povidone iodine and traumatic wound cleansing. | 2006 Nov |
|
| Comparative cytotoxicity of high-osmolar and low-osmolar contrast media on HKCs in vitro. | 2006 Nov-Dec |
|
| The treatment of Graves' disease in children. | 2006 Sep |
|
| Sodium iodide symporter is expressed at the preneoplastic stages of liver carcinogenesis and in human cholangiocarcinoma. | 2007 Apr |
|
| Goiter and other iodine deficiency disorders: A systematic review of epidemiological studies to deconstruct the complex web. | 2007 Jan |
|
| [Effects of iodine excess and selenium supplement on the levels of thyroid hormone and its receptor expression in filial cerebrum of mice]. | 2007 Mar |
|
| Enhanced expression of adenovirus-mediated sodium iodide symporter gene in MCF-7 breast cancer cells with retinoic acid treatment. | 2007 Mar |
|
| Increased iodine uptake in thyroid carcinoma after treatment with sodium butyrate and decitabine (5-Aza-dC). | 2007 Nov |
|
| Comparison of the usefulness of gadodiamide and iodine mixture versus iodinated contrast alone for prevention of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography. | 2007 Oct 1 |
|
| [Suggestions for prevention of adverse reactions after intravasal administration of iodinated contrast media]. | 2008 |
|
| [The effects of iodine/selenium on the function of antigen presentation of peritoneal macrophages in rats]. | 2008 Jul |
|
| Gadolinium and kidney disease: are your patients at risk? | 2008 Mar-Apr |
|
| Use of gadolinium for carotid artery angiography and stenting in patients with renal insufficiency. | 2009 Dec |
|
| I-131 dose response for incident thyroid cancers in Ukraine related to the Chornobyl accident. | 2011 Jul |
|
| The effects of ammonium perchlorate on thyroid homeostasis and thyroid-specific gene expression in rat. | 2012 Aug |
|
| Sensitivity of human dental pulp cells to eighteen chemical agents used for endodontic treatments in dentistry. | 2013 Jan |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
LOINC |
25448-2
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
||
|
LOINC |
50868-9
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
||
|
LOINC |
34321-0
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
||
|
WHO-VATC |
QD08AG03
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
||
|
LOINC |
34320-2
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
||
|
LOINC |
76657-6
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
||
|
LOINC |
55928-6
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
||
|
LOINC |
53872-8
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
||
|
LOINC |
25936-6
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
||
|
LOINC |
25449-0
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
||
|
NCI_THESAURUS |
C896
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
||
|
WHO-ATC |
D08AG03
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
||
|
WHO-VATC |
QD08AG53
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
||
|
EPA PESTICIDE CODE |
46905
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
||
|
LOINC |
2494-3
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
||
|
LOINC |
44323-4
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
||
|
LOINC |
26842-5
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
||
|
LOINC |
2492-7
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
||
|
DSLD |
184 (Number of products:5290)
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
||
|
DEA NO. |
6699
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
27
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
||
|
LOINC |
2495-0
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
17606
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
PRIMARY | |||
|
D007455
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
PRIMARY | |||
|
C594
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
PRIMARY | |||
|
34
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
PRIMARY | |||
|
7553-56-2
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
PRIMARY | |||
|
Tincture of iodine
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
PRIMARY | |||
|
231-442-4
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
PRIMARY | |||
|
m6327
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
PRIMARY | Merck Index | ||
|
9679TC07X4
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
PRIMARY | |||
|
Iodine (medical use)
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
PRIMARY | |||
|
807
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
PRIMARY | |||
|
9679TC07X4
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
PRIMARY | |||
|
SUB14239MIG
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
PRIMARY | |||
|
DB05382
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
PRIMARY | |||
|
IODINE
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
PRIMARY | Description: Heavy, greyish black plates or granules, having a metallic lustre. Solubility: Very slightly soluble in water; soluble in ethanol (~750 g/l) TS; freely soluble in carbon tetrachloride R, carbon disulfide R, and ether R. Category: External antiseptic. Storage: Iodine should be kept in a tightly closed container, preferably made of glass and provided with a glass stopper. Additional information: Iodine volatilizes slowly at room temperature giving violet, irritant vapours. Definition: Iodine contains not less than 99.5% and not more than 100.5% of I. | ||
|
42355
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
PRIMARY | |||
|
5933
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
PRIMARY | RxNorm | ||
|
4446
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
PRIMARY | |||
|
Iodine
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
PRIMARY | |||
|
100000092589
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
PRIMARY | |||
|
DTXSID7034672
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
PRIMARY | |||
|
24859
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
PRIMARY | |||
|
CHEMBL1201225
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
PRIMARY | |||
|
Iodine
Created by
admin on Fri Dec 15 15:32:49 UTC 2023 , Edited by admin on Fri Dec 15 15:32:49 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
